Introduction {#s02}
============

The eukaryotic genome is packaged and organized in chromatin. The nucleosome, the basic unit of chromatin, consists of an octamer with two copies each of the core histone H2A, H2B, H3, and H4 around which is wrapped ∼146 bp of DNA and a variable linker DNA associated with the linker histone H1. The core histones share a conserved histone-fold domain that mediates their head-to-tail heterodimerization. In this way, H2A and H2B form two dimers flanking a (H3-H4)~2~ tetramer. The less conserved linker histones, the H1 family, possess a central globular domain flanked by a short N-terminal tail and a long basic C terminus. All histone families exist as variants that are differentially expressed and can undergo several posttranslational modifications. A variety of nucleosomes thus use distinct histone variants, as well as posttranslational modifications with different properties often associated with specific chromatin states ([@bib176]; [@bib146]). As the major protein component of chromatin, histones are critical for its dynamic organization, assembly, and disassembly during most DNA transactions. However, because of their basic nature, uncontrolled histone accumulation can lead to promiscuous interactions with any acidic component, forming aggregates that are ultimately cytotoxic. Nonnucleosomal histones are therefore constantly under check. From their synthesis to incorporation into chromatin, as well as during disassembly and disposal, histones are escorted by distinct histone chaperones ([@bib71]; [@bib72]). The first protein designated as a histone chaperone is nucleoplasmin, discovered as the major protein present in *Xenopus laevis* oocytes ([@bib97]). Mainly in charge of H2A-H2B, it functions along with the H3-H4 N1/N2 chaperones to provide a stockpile of maternal core histones. During early development, this storage of maternal core histones is required to assemble newly replicating DNA into chromatin, thereby sustaining the first rounds of rapid cell division ([@bib194]; [@bib46]). Under this unusual situation, particular chaperones are thus needed to cope with massive amounts of soluble histones. In contrast, in cycling cells, the soluble reservoir is more limited and has long been ignored. Not only are histone chaperones in charge of the cytosolic reservoir of histones or histones in transit but, most importantly, they also promote the deposition, eviction, and recycling of specific histone variants during DNA replication, transcription, and repair. Physiological changes in the level of histone chaperones and histone variants occur at various times during development, such as the up-regulation of nucleoplasmin in *Xenopus* female germ cells to accommodate the pool of maternal histones ([@bib97]), the accumulation of H3.3 in rat postmitotic neurons when cells have exited from the cell cycle ([@bib137]), and the up-regulation of the chaperone ASF1b in highly proliferating cells ([@bib31]). A major interest has thus arisen concerning the interplay between histone variants and their dedicated chaperones to maintain chromatin integrity during development, differentiation, and the entire lifespan of an individual ([@bib38]; [@bib50]; [@bib71]; [@bib72]).

In this review, considering histone H3 variants and their expression during the cell cycle, we will describe how different mechanisms control the amounts of histones. H3 variants recently emerged as important actors in cancer biology, as they are altered or misregulated across different types of tumors ([@bib183]; [@bib187]). Distinct variants are under tight regulation to meet various demands along the cell cycle and mark specific functional domains in the genome ([@bib71]; [@bib163]). A notable example is CenH3^CENP-A^, a rapidly evolving variant that specifically marks the centromere. Other H3 variants show a high degree of sequence similarity and are associated with different domains. Based on their deposition pathway, H3 variants can be distinguished as replicative and non-replicative. Replicative forms are specialized variants whose expression peaks in S phase and whose incorporation is coupled to DNA synthesis. During S phase, a provision of replicative H3 variants (H3.1 and H3.2) supports the bulk assembly of chromatin onto newly synthesized DNA. In contrast, the constitutive expression of the non-replicative variant H3.3 sustains histone turnover throughout the cell cycle, representing the majority of histones in quiescent and terminally differentiated cells. The other non-replicative variant, CenH3^CENP-A^, is specifically deposited at centromeres and marks the site of kinetochore assembly. Its expression peaks in G2/M phase in mammalian cells, and its deposition occurs only late in mitosis/early G1. Interestingly, replicative histone genes show a particular organization in clusters not observed for replacement histones, providing a unique means for controlling their expression.

We will first briefly review our current knowledge on the dynamics and deposition of these histone variants onto DNA, considering both dedicated and general chaperones. Next, we will describe recent advances concerning the regulation of their expression and the impact on genome organization and function throughout the cell cycle. Finally, we will put forward a few examples of aberrant expression of histone genes and discuss the consequences of their imbalance.

Dedicated chaperones for dynamics and deposition of replicative and non-replicative histone variants {#s03}
====================================================================================================

The deposition of H3 variants involves different histone chaperones and leads to a partitioning of the genome in distinct chromosomal domains ([Fig. 1, A and B](#fig1){ref-type="fig"}). In S phase, the doubling of genomic content requires a massive provision of histones to ensure the duplication of chromatin ([@bib30]; [@bib4]). Nucleosomes ahead of the replication fork are displaced, and histones are recycled onto newly replicated DNA along with de novo deposition of new histones to restore nucleosome density ([@bib138]; [@bib6]). This leads to the mixing of new and parental histones along with their particular marks, thereby enabling the propagation of active and repressive states to subsequent cell generations ([@bib142]; [@bib146]). Orchestration of histone incorporation and recycling during S phase involves mechanisms coupled to DNA synthesis and dedicated histone chaperone complexes. The chromatin assembly factor-1 (CAF-1) complex is the H3-H4 histone chaperone that promotes nucleosome assembly coupled to DNA synthesis during replication ([@bib164]) and repair ([@bib59]). CAF-1 is recruited at replication forks through the interaction of its p150 subunit with the proliferating cell nuclear antigen (PCNA) ([@bib118]), a processivity factor for the DNA polymerase. The CAF-1 complex associates specifically with the replicative variant H3.1 and H3.2, coupling their deposition to DNA synthesis ([@bib175]; [@bib98]).

![**Enrichment of histone H3 variants and their deposition by dedicated chaperones. (A)** Genomic distribution of H3.1, H3.3, and CenH3 from published ChIP-Seq data in HeLa cells ([@bib94]; [@bib28]). The plot shows the enrichment relative to input for all variants at a representative region spanning the centromere and the proximal short and long arms of chromosome 18 (p11.21-q21.1). The enrichment is computed as the log~2~ ratio between the mean per-base number of reads from H3.1 (purple), H3.3 (green), and CenH3 (blue) and their respective input, at consecutive 10-kb bins (smoothed over five nonzero bins). Enriched regions are highlighted in darker colors, illustrating the partitioning of the genome into chromatin domains associated with specific variants. **(B)** Schematic representation of the histone chaperones involved in the deposition of H3 variants at distinct chromosomal locations. The DAXX/ATRX complex promotes the accumulation of the non-replicative variant H3.3 at telomeres and pericentric heterochromatin. H3.3 is also deposited at actively transcribed regions and regulatory sites by HIRA, a complex consisting of three subunits: CABIN1, HIRA, and UBN1. The non-replicative variant CenH3 is deposited specifically at centromeres by its dedicated chaperone HJURP, marking the site of kinetochore assembly. Both H3.1 and H3.3 are incorporated at centromeres during S phase, and H3.3 acts as a placeholder for CenH3 loading in late mitosis and early G1. H3.1 is deposited genome-wide by the CAF-1 complex during S phase, or at DNA repair sites throughout the cell cycle. The CAF-1 complex consists of three subunits: p48, p50, and p160. The p150 subunit interacts with PCNA and promotes CAF-1 recruitment at replication forks. This couples H3.1 deposition to DNA synthesis and ensures proper chromatin assembly during replication. ASF1 is a general chaperone that can handle both H3.1 and H3.3 and hands them over to their dedicated chaperones. **(C)** Illustration of high-resolution visualization by STORM of H3.1 and H3.3 along S phase (adapted from [@bib28]). The STORM images show the nuclear distribution of H3.1 and H3.3 (HA staining, in red) at sites of DNA synthesis (EdU staining, in green) in early and mid/late S. Scale bars represent 5 µm. Insets represent enlarged images of selected areas where scale bars correspond to 600 nm. H3.3 clusters show stable volume, but there is a decrease in H3.3 density as S phase progresses; the late domains likely show a dilution of H3.3 during DNA replication. In contrast, H3.1 clusters change in both volume and density during S phase, with larger H3.1 clusters and low densities in early S and clusters with smaller volumes and higher density in mid/late S phase. See [@bib28] for further details.](JCB_201807179_Fig1){#fig1}

Antisilencing function 1 (ASF1) is a H3-H4 chaperone viewed as an intermediary handing over distinct histone variants to their specific chaperones ([@bib116]; [@bib34]; [@bib178]). ASF1 is rather promiscuous and can interact with all H3 variants, including H3.1, H3.3, and CenH3^CENP-A^. Initially implicated in the deposition of new histones ([@bib181]), ASF1 also regulates their supply during replication ([@bib66]). Moreover, it plays a critical role in coupling histone dynamics with the progression of the replicative helicase during S phase ([@bib67]). At replication forks, ASF1 forms a complex with the MCM2 subunit of the MCM helicase and binds H3-H4 dimers associated with the MCM2 histone-binding domain ([@bib67]; [@bib77]; [@bib147]). MCM2 might act as a chaperone to unload parental H3-H4 tetramers ahead of the fork, while the association with two ASF1 could help dissociating the tetramers in two dimers of parental histones ([@bib27]). ASF1 is thus ideally positioned to handle both parental and new histones. The distribution of global and parental H3.1 and H3.3 throughout S phase has been determined by superresolution microscopy ([Fig. 1 C](#fig1){ref-type="fig"}), which demonstrated that, in addition to causing a global loss of parental H3, ASF1 depletion leads to a relocalization of parental histones away from replication foci. This affects the distribution of both replicative and non-replicative H3 variants. Both exhibit a distinct nuclear distribution, and the effect of ASF1 loss differs between variants depending on replication timing ([@bib28]).

Chromatin assembly is also required to sustain the turnover of histones that occurs independently of the cell cycle. This is mostly mediated by a replication- and cell cycle--independent pathway that involves the deposition of the histone variant H3.3 ([@bib1]). The HIRA complex associates specifically with H3.3 ([@bib175]). The complex consists of three protein subunits: histone cell cycle regulator (HIRA), ubinuclein-1 (UBN1), and calcineurin binding protein 1 (CABIN1). H3.3 is incorporated into chromatin throughout the cell cycle and accumulates in postmitotic cells. It is mainly associated with transcribed regions and regulatory sites with high nucleosome turnover ([@bib63]) but also, more broadly, at any given location where a gap occurs ([@bib143]). At active promoters, HIRA colocalizes with H3.3, UBN1, and ASF1a ([@bib134]). HIRA coordinates with ASF1a to mediate the deposition of histone H3.3 in a replication-independent manner. If CAF-1 fails to assemble nucleosomes, the HIRA complex can provide a fallback strategy. The current model proposes that HIRA, owing to its ability to bind naked DNA in vitro, promotes H3.3 deposition in a gap-filling fashion at nucleosome-free regions ([@bib143]). The recently identified homotrimerization property of HIRA subunit is required for CABIN1 binding and is critical for its functional activity ([@bib144]). HIRA also promotes nucleosome reassembly after nonhomologous end joining in a replication-independent manner, and CAF-1 in a DNA synthesis-coupled manner ([@bib100]). Thus, the two chaperones act in concert, balancing each other to ensure chromatin maintenance. This recently discovered homotrimerization property of the HIRA subunit resembles the trimerization of the yeast Ctf4, a component of the replication machinery present at replication forks ([@bib161]), and is likely required for CABIN1 binding to ensure histone deposition at DNA damage sites ([@bib144]).

Besides transcribed regions, H3.3 is also deposited at specific chromosomal landmarks independent of HIRA. The death domain--associated protein DAXX and the chromatin remodeling factor α-thalassemia/mental retardation syndrome protein (ATRX) promote the enrichment of H3.3 at pericentric heterochromatin and telomeres ([@bib42]; [@bib63]). The DAXX/ATRX complex associates with H3.3 at telomeres in a replication-uncoupled manner. H3.3-H4 dimers directly interact with DAXX via its histone-binding domain. ATRX is dispensable for the interaction but contributes to target DAXX at specific chromatin domains, thereby promoting DAXX-dependent H3.3 accumulation ([@bib99]). In addition, the oncoprotein DEK has been involved in the differential distribution of H3.3 by HIRA and DAXX/ATRX in somatic and embryonic stem cells. DEK can help in loading ATRX, and hence H3.3, on telomeric regions, thereby maintaining telomere integrity ([@bib79]).

The dedicated chaperone Holliday junction recognition protein (HJURP) ensures CenH3^CENP-A^ loading at centromeres ([@bib43]; [@bib54]). CenH3^CENP-A^ specifically marks the centromere and is required for kinetochore assembly and proper chromosome segregation during cell division. During replication, CenH3^CENP-A^ is diluted while H3.1 and H3.3 are deposited, and H3.3 is likely used as a placeholder for newly assembled CenH3^CENP-A^ ([@bib44]), which is deposited later during late telophase/early G1 ([@bib82]; [@bib15]). Phosphorylation of HJURP is required to ensure proper timing of CenH3^CENP-A^ incorporation, as nonphosphorylatable mutants localize to centromeres throughout the cell cycle ([@bib124]).

As outlined above, histone chaperones are generally in charge of dedicated histone cargos and promote the deposition of specific variants, whereas others, like ASF1, are more promiscuous. For further details on H3 variants and their chaperones, we direct the reader to recent reviews ([@bib121]; [@bib163]). Remarkably, under particular circumstances, some chaperones can substitute for each other when one is either missing or limiting. Thus, chaperone function can show some degree of overlap. This has been observed upon DAXX depletion when a fraction of the replacement variant H3.3 associates with the replicative assembly machinery ([@bib42]), or when HIRA backs up CAF-1 to fill nucleosome gaps behind the fork ([@bib143]), or when DAXX handles excess CenH3^CENP-A^ in place of HJURP upon CenH3^CENP-A^ overexpression ([@bib94]). Such cross-talk between histone chaperones and their choice of histone variant can thus provide robustness in the process of histone management and suggests a potential for chromatin plasticity.

Mechanisms for deposition and dynamics in and out of chromatin are thus critical. They involve DNA synthesis--coupled pathways for replicative variants and DNA synthesis--uncoupled pathways for non-replicative ones. Beyond handling histones, their regulation and production play an equally important role to meet different cellular demands. We will next discuss how the expression of replicative and non-replicative variants is regulated.

Replicative histone variants: A unique genomic organization and regulation at multiple levels {#s04}
=============================================================================================

Chromatin assembly in S phase requires vast amounts of newly synthesized histones to ensure its restoration on the duplicated genome. Replicative histone variants share a unique transcriptional program that ensures higher expression levels for DNA synthesis--coupled deposition in S phase. In contrast to replacement variants, H3.1 and H3.2 genes show a peculiar organization in clusters that comprise multiple copies of all core histones and the H1 linker. This offers a potential means to optimize coregulation. Indeed, in the human and mouse genome, replicative histone genes cluster at three syntenic loci that remained physically linked through evolution ([@bib111]). The human histone cluster 1 (HIST1) is located on chromosome 6 (6p22) and comprises more than 50 coding genes, while HIST2 and HIST3 are located on chromosome 1 (1q21 and q42) and contain, respectively, 10 and 3 coding genes. Besides their physical proximity, genes are compartmentalized and processed in nuclear bodies that concentrate the factors required for their transcription and processing. These bodies were initially thought to coincide with Cajal bodies, subnuclear compartments discovered at the beginning of the century ([@bib20]) and implicated in the biogenesis of ribonucleoproteins associated with histone pre-mRNAs ([@bib56]; [@bib21]; [@bib102]). The presence of separate histone locus bodies (HLBs) dedicated to the transcription of replicative histones was only recognized later ([@bib103]). Similar to Cajal bodies, HLB foci are marked by coilin, but they form at distinct subnuclear locations and coilin is dispensable for their assembly ([@bib104]). The nuclear compartmentalization of replicative histone genes is also reflected by their higher-order organization ([@bib140]; [@bib57]). Higher-order structures can be revealed from self-interacting regions where contacts among genome sequences in physical proximity occur more frequently (topologically associating domains \[TADs\]). The three gene subsets in the human cluster 1 interact within separate TADs. Notably, these TADs further interact with each other over an ∼1.5-Mb distance, indicating that separate genes also establish long-range contacts and come in physical proximity within the nucleus ([Fig. 2 A](#fig2){ref-type="fig"}). The distinctive interplay among replicative histone genes is thus apparent at multiple dimensions, but it is still unclear how these layers of organization relate to each other. HLBs might represent a case of self-organization ([@bib113]) or an example of phase-separated nuclear bodies that assemble via liquid demixing by macromolecular crowding ([@bib208]; [@bib45]). This might resemble the phase separation recently implicated in the formation of heterochromatin protein 1 (HP1) foci ([@bib96]; [@bib168]) and repetitive RNA foci ([@bib80]). It would be interesting to experimentally address the link between phase transitions and the assembly of HLBs. Transgenic assays in *Drosophila melanogaster* revealed that a sequence located between histone H3 and H4 genes is important to mediate HLB assembly. Neither the H3 and H4 coding region nor the 3′ signals are required for HLB formation ([@bib154]). Chromatin-linked adaptor for male-specific lethal (CLAMP) is a zinc finger protein that binds the GA repeat motif within bidirectional H3-H4 promoter and controls chromatin accessibility, thereby enhancing transcription and promoting HLB formation ([@bib148]). Much remains to be understood concerning how their transcriptional regulation exploits this particular 3D organization.

![**Higher-order organization of replicative histone genes and compartmentalization of nuclear factors in HLBs.** Replicative histones are redundantly encoded by multiple intronless genes that exhibit a conserved cluster organization across several lineages. **(A)** Location and spatial interactions among histone genes within the human histone cluster 1 (HIST1). The contact matrix was generated using iteratively corrected Hi-C data in GM12878 cells at 10-kb resolution ([@bib140]) and plot with gcMapExplorer ([@bib90]). Genome bins where histone genes are located are marked in purple, illustrating the presence of three separate subsets within the HIST1 cluster. Neighboring genes in each subset interact within separate TADs, but all three subsets further engage in long-range interactions that bring distant genes together over an ∼1.5-Mb distance. This spatial organization might reflect the compartmentalization of replicative histone genes in the nucleus. Their pre-mRNAs are indeed transcribed and processed in dedicated nuclear bodies, called HLBs. **(B)** Nuclear distribution of NPAT, an essential factor driving HLB assembly and transcription initiation. The confocal image was retrieved from the Human Protein Atlas (v.18) and shows NPAT staining in U2-OS cells (in green). The nucleus and microtubules are stained in blue and red, respectively. NPAT concentrates at distinct subnuclear locations and marks the HLBs.](JCB_201807179_Fig2){#fig2}

Besides their distinctive genomic and subnuclear organization, replicative histones differ from replacement variants in terms of gene architecture and mRNA processing. Virtually all genes in the histone clusters lack introns, have relatively short UTRs, and produce transcripts that harbor a conserved 3′ stem-loop structure and do not undergo polyadenylation in many organisms ([@bib112]; [@bib45]; [@bib115]). The only processing needed to form a mature histone mRNA is the endonucleolytic cleavage of its precursor. This is mediated in cis by the 3′ stem-loop and a purine-rich sequence downstream of the cleavage site, the histone downstream element (HDE). These features are widely conserved in metazoans as well as unicellular eukaryotes ([@bib36]; [@bib112]) but are not found in species, such as *Saccharomyces cerevisiae*, that lack DNA synthesis--coupled histone variants ([@bib48]). In budding yeast, there is a single H3.3-like variant whose expression is induced in S phase together with other histone gene pairs ([@bib130]). Histone repression outside of S phase is mediated by several factors, including the yeast orthologues of several known chaperones such as HIR1, HIR2, and HIR3 ([@bib159]; [@bib166]) as well as Asf1 ([@bib174]). In addition, histone transcription is also regulated by Spt10, a putative acetyltransferase, together with its partner Spt21 ([@bib91]). At the protein level, Rad53 participates as part of a surveillance mechanism that monitors the accumulation of excess histone proteins and triggers their degradation ([@bib70]; [@bib162]). This mode of regulation at the level of protein stability is not unique to budding yeast but is further exploited in other organisms. Indeed, the human histone chaperone nuclear autoantigenic sperm protein (NASP), similar to the *Xenopus* N1/N2, maintains a cytosolic soluble pool of H3-H4 dimers and protects them from degradation via chaperone-mediated autophagy ([@bib29]).

In organisms with replicative histone variants, their expression throughout the cell cycle is controlled at multiple levels ([@bib141]). Replicative histone genes are transcribed and processed by several factors within the HLBs ([Fig. 3](#fig3){ref-type="fig"}). Transcription initiation is controlled by cyclin E/CDK2-dependent phosphorylation of the nuclear protein, ataxia-telangiectasia locus (NPAT) at the G1/S transition. Phosphorylated NPAT is required to initiate the assembly of HLBs and persists throughout S phase to activate the expression of replicative histone genes ([@bib106]; [@bib206]; [@bib190]). NPAT also interacts with FLICE-associated huge protein (FLASH), an essential cofactor involved in HLB assembly and 3′ processing of nascent transcripts ([@bib12]; [@bib202]; [@bib190]). Pre-mRNA maturation relies on the recognition of the cis-regulatory elements at the 3′ end by two factors that are specific to replicative histones: the stem-loop binding protein (SLBP) and the U7 snRNP ([@bib119]; [@bib39]; [@bib170]; [@bib207]). The U7 snRNP is a ribonucleoprotein complex composed of U7 snRNA, Sm proteins, and U7-specific Lsm10 and Lsm11 proteins ([@bib135], [@bib136]). The 5′ end of the complex binds histone pre-mRNAs via U7 snRNA hybridization to the 3′ HDE sequence ([@bib32]; [@bib165]). SLBP binds the stem-loop upstream and interacts with the U7 snRNP to stabilize its association. This stabilization is required for proper maturation and cleavage of histone pre-mRNAs ([@bib132]; [@bib170]) but might be dispensable in vitro if the RNA duplex is sufficiently stable ([@bib167]; [@bib39]).

![**Cell cycle timing and regulation of replicative histone genes.** The replicative variant H3.1 is deposited by CAF-1 in a DNA synthesis--coupled manner, mostly during replication in S phase. Expression peaks at the G1/S transition, and its transcription is regulated in concert with other replicative histone genes located within the histone clusters. Their pre-mRNAs are processed through a distinct pathway that involves the recognition of two unique cis-regulatory elements: a 3′ stem-loop structure and an HDE. Transcription and pre-mRNA processing are compartmentalized in the nucleus and coordinated in HLBs. HLB assembly and transcriptional activation is initiated by NPAT. NPAT is phosphorylated by the Cyclin E/CDK2 complex at the G1/S transition. The maturation of histone pre-mRNAs requires the endonucleolytic cleavage of its 3′ tail and is mediated by several factors recruited to HLBs. The U7 snRNP binds the HDE via hybridization of the U7 snRNA. It interacts with SLBP, a protein that specifically recognizes the 3′ stem-loop structure and stabilizes the U7 snRNP association. FLASH is another essential coactivator that promotes the recruitment of transcription factors and interacts with the Lsm11 subunit of the U7 snRNP to recruit the components of the histone cleavage complex. These transcription factors include Symplekin and the CPSF73/CPSF100 heterodimer that catalyzes the 3′ end endonucleolytic cleavage. Mature mRNAs are cleaved downstream of the 3′ stem-loop, which is required for mRNA degradation. SLBP is also degraded at the end of S phase after phosphorylation by the Cyclin A/CDK1 complex. H3 availability is further modulated at the protein level by NASP, a H3-H4 histone chaperone that protects soluble histones from degradation via chaperone-mediated autophagy counteracting Hsc70 and Hsp90.](JCB_201807179_Fig3){#fig3}

Pre-mRNA cleavage is catalyzed by the CPSF73 endonuclease ([@bib40]; [@bib109]). The interaction between FLASH and the U7-specific protein Lsm11 is critical for CPSF73 recruitment at the cleavage site ([@bib18]; [@bib203]). SLBP, U7 snRNP, and FLASH contribute to recruit scaffolding factors and additional components of the histone cleavage complex. The core components include Symplekin ([@bib86]; [@bib179]) and CPSF100, which heterodimerizes with CPSF73 to catalyze the endonucleolytic cleavage of the 3′ end ([@bib40]; [@bib87]). Other factors ([@bib45]) might contribute to stabilize interactions in the cleavage complex that are specific to the processing of histone pre-mRNAs. mRNA levels of replicative histones decrease at the end of S phase, and SLBP is degraded upon phosphorylation by cyclin A/CDK1 ([@bib88]). The 3′ stem-loop structure is necessary and sufficient for the degradation of histone mRNAs ([@bib65]; [@bib131]). Degradation is also regulated via 3′ end uridylation by the uridylyltransferase TUT7 ([@bib120]; [@bib93]), and the 3′hExo enzyme is needed in the initial steps ([@bib201]). The mechanism underlying 3′ end recognition to allow 3′hExo to initiate degradation of the stem-loop is not well understood but might involve elements downstream of the stop codon ([@bib65]).

Besides factors that are specific to the processing of replicative histones, several common targets and transcriptional regulators contribute to expression in the HLB (also summarized in [Fig. 3](#fig3){ref-type="fig"}). Human histone genes harbor TATA, CCAAT, and GC boxes in their promoter region, as well as putative binding sites for several transcription factors ([@bib110]). In human cells, FLASH participates in the recruitment of coactivators, such as p73, that contribute to the transcription of replicative histones ([@bib37]). In the tandemly arrayed linker and core histone clusters of *Drosophila*, the TATA-binding protein TBP regulates the transcription of core histones, while H1 genes have TATA-less promoters modulated by the TBP related factor, TRF2 ([@bib78]). The core and linker histones are indeed differentially expressed in flies, with H1 transcribed throughout the S phase and the core histones induced during a short pulse in early S phase ([@bib68]). Myc also colocalizes to the *Drosophila* HLB and contributes to the expression of replicative histone genes ([@bib35]). In mouse embryonic stem cells, several chromatin factors such as E2f1, Ctcf, Smad1, and Yy1 are likely to be involved in the regulation of both core and linker histones ([@bib62]). The contribution of different factors to the transcription of specific genes is still unclear and might vary among lineages ([@bib110]) as well as in a tissue- and developmental-specific manner. The transcription elongation rate also affects the pre-mRNA folding at the 3′ end. Stem-loop formation is impaired in slow elongation conditions following UV irradiation or RNA polymerase II mutation, which leads to an accumulation of polyadenylated histone mRNAs ([@bib153]). The negative elongation factor (NELF) interacts with the nuclear cap binding complex (CBC) and plays a role in the 3′ processing. Their combined knockdown leads to increased expression of replicative histone genes, and CBC was shown to interact directly with SLBP. Both NELF and CBC physically associate with the histone gene body, and NELF accumulates in nuclear foci where histone cleavage factors localize ([@bib125]). Genome-wide RNAi screens in *Drosophila* showed that depletion of H3.3 and H2Av disrupts the expression of replicative histones ([@bib184]). The U7 snRNP fails to accumulate at the HLB when H2Av is mutated. Although the effect may be indirect, this suggests that histone variants themselves might play a role in transcriptional processing.

The regulation of specific genes within the histone clusters has yet to be characterized systematically. Nonetheless, their unique cis-regulatory features and distinctive organization ensures a coordinated processing that enables a precise temporal control of their expression. This regulation is critical for cell cycle progression and has important implications for both genome and epigenome assembly. The cross-talk between 3D organization in the nucleus and transcription is surely a remarkable paradigm, and the link between HLBs and topological domains is a promising avenue for investigation. Such studies might also give important insights into the coregulation of genes induced synchronously by other cues.

Distinct transcriptional regulation and cell cycle expression of the centromeric variant CenH3 {#s05}
==============================================================================================

In contrast to replicative variants, CenH3^CENP-A^ is encoded by a single multi-exon gene located outside of histone clusters ([@bib171]; [@bib145]). CenH3^CENP-A^ expression is regulated through a distinct, DNA synthesis--independent pathway ([Fig. 4](#fig4){ref-type="fig"}). Transcripts lack a 3′ stem-loop and undergo conventional processing through splicing and polyadenylation. The expression of CenH3^CENP-A^ peaks in G2, and this temporal control is key for its centromeric targeting ([@bib158]). Induction of CenH3^CENP-A^ during S phase leads to a loss of specific targeting and misassembly at chromosome arms. CenH3^CENP-A^ deposition occurs in telophase/early G1 ([@bib82]). HJURP, its chaperone, is recruited at the centromere during this critical time window and is otherwise distributed throughout the nucleoplasm and at nucleoli ([@bib43]). A controlled expression of CenH3^CENP-A^ is necessary to prevent promiscuous interactions with low-affinity chaperones and aberrant CenH3^CENP-A^ loading ([@bib94]; [@bib160]). Thus, ensuring an exclusive handling by HJURP is likely critical for proper deposition of CenH3^CENP-A^. Its periodic regulation is indeed a widely conserved feature, and CenH3^CENP-A^ mistargeting occurs in a variety of distant species whenever the gene is ectopically expressed at constitutively high levels ([@bib182]; [@bib73]; [@bib60]; [@bib117]; [@bib26]; [@bib94]).

![**Cell cycle timing and regulation of the centromeric variant CenH3.** The non-replicative variant CenH3^CENP-A^ is deposited at centromeres by its dedicated chaperone HJURP in telophase/early G1. Its expression is regulated in a cell cycle--dependent manner and peaks in G2/M. CenH3^CENP-A^ is encoded by a single multi-exon gene located outside of the histone clusters that undergoes conventional pre-mRNA processing via splicing and polyadenylation. Transcription is coordinated in concert with other late cell cycle genes, including HJURP. This is regulated in cis by the CHR/CDE motif in their promoter region. The recruitment of the DREAM complex at the CHR is thought to promote transcriptional repression during G1. At the beginning of S phase, the MuvB core of the DREAM complex remains bound to the CHR/CDE while other components dissociate and are replaced by B-MYB. The B-MYB-MuvB (MMB) complex recruits FOXM1 in late S phase. B-MYB is degraded upon phosphorylation, whereas the progressive phosphorylation of FOXM1 leads to its activation in G2/M. Both CenH3 and HJURP are induced at the same time and mutually stabilize each other at the protein level. The reciprocal stabilization is affected by posttranslational modifications on the N-terminal tail of CenH3, which further regulate the timing of deposition. S69 phosphorylation prevents interaction with HJURP and premature loading, while K124 ubiquitylation favors HJURP binding and might contribute to their stabilization.](JCB_201807179_Fig4){#fig4}

The regulation of both CenH3^CENP-A^ and HJURP is coordinated in concert with other late cell cycle genes involved in mitotic progression, such as *CDC25B*, *AURKB*, *PLK1*, and *CENP-B* ([@bib185]). Expression of these genes peak in G2/M, and they harbor a conserved cell cycle--dependent element (CDE) and cell cycle genes homology region (CHR) in their promoter ([@bib123]). During G1 phase, CHR promotes their transcriptional repression via recruitment of the dimerization partner, RB-like, E2F, and MuvB (DREAM) complex ([@bib150]). Binding of DREAM components to the CHR can be also facilitated by the upstream CDE sequence ([@bib122]). When cells progress into S phase, DREAM components dissociate from the MuvB core complex and B-MYB binds to MuvB. The B-MYB-MuvB (MMB) complex recruits FOXM1 to the CHR site in late S phase. B-MYB is hence phosphorylated and undergoes proteasome degradation, whereas MuvB remains bound to FOXM1 ([@bib41]; [@bib151]). The progressive phosphorylation of FOXM1 by cell cycle--dependent kinases finally promotes its activation in G2/M ([@bib58]; [@bib95]; [@bib25]), which leads to maximal induction of CHR-harboring genes bound by the MuvB-FOXM1 complex.

The CDE/CHR motif in CenH3^CENP-A^ promoter was early recognized as a potential cis-regulatory element underlying its periodic expression ([@bib158]). CenH3^CENP-A^ is a direct target of FOXM1 ([@bib185]; [@bib24]), together with HJURP and other mitotic genes. In human and mouse cells, FOXM1 depletion leads to reduced CenH3^CENP-A^ expression and impaired mitotic progression ([@bib185]). Both CenH3^CENP-A^ and HJURP also proved to be potential targets of the DREAM repressor complex ([@bib53]). Notably, their CDE/CHR motif facilitates transcriptional repression upon p53-dependent recruitment of DREAM in mouse cells ([@bib52]). Furthermore, p53 activation also leads to down-regulation of HJURP and CENP-A in human cells. Whether CenH3^CENP-A^ repression during G1/S is likewise dependent on DREAM has yet to be confirmed. Nevertheless, the fine-tuning of CenH3^CENP-A^ kinetics is likely constrained by the need to preserve its precise centromeric targeting.

Besides their transcriptional coregulation, CenH3^CENP-A^ and HJURP are dedicated binding partners, and their interaction plays an important role in maintaining a homeostatic balance. CenH3^CENP-A^ and HJURP coexist as a soluble complex in which each of them favors the reciprocal stabilization of the other ([@bib13]; [@bib52]). The N-terminal portion of HJURP binds both CenH3 and H4, thereby protecting the dimers locally at the region of contact ([@bib13]). The specific interaction with HJURP is driven by the centromere targeting domain (CATD) of CenH3^CENP-A^ and favors the stabilization of nonnucleosomal dimers. Exogenous overexpression of either CenH3^CENP-A^ or HJURP leads to an increase in the endogenous levels of their binding partner ([@bib52]). HJURP loss results in CenH3^CENP-A^ depletion, and CenH3^CENP-A^ knockdown leads to the proteasome-mediated degradation of HJURP. The interaction between the two could be further modulated by posttranslational modifications in CenH3^CENP-A^ N-terminal tail. For instance, CDK1/cyclin B--dependent phosphorylation at serine 68 during G2/M hinders the interaction with HJURP, preventing premature loading of CenH3^CENP-A^ at centromeres ([@bib75]; [@bib204]; [@bib186]). Ubiquitylation at lysine 124 instead facilitates their interaction and might control the stability of the complex ([@bib127]). The CUL4A-RBX1-COPS8 complex mediates CenH3^CENP-A^ lysine 124 ubiquitylation ([@bib127], [@bib128]), but the deubiquitylating enzyme has not yet been identified. Posttranslational modifications and their effect on CenH3 stability vary significantly across species, consistent with the low conservation of its N-terminal tail ([@bib10]; [@bib11]). The underlying pathways might represent potential adaptations to consider in light of its rapid evolution ([@bib108]; [@bib92]) or coevolution with their dedicated chaperone ([@bib155]; [@bib149]).

Constitutive expression of the non-replicative H3.3 variant by independent paralogs {#s06}
===================================================================================

H3.3 is constitutively expressed in a cell cycle--independent manner, supporting histone turnover outside of S phase and in quiescent or postmitotic cells ([@bib195]; [@bib198], [@bib199]) and histone replacement after fertilization in *Drosophila* ([@bib105]) and mice ([@bib81]; [@bib177]). H3.3 is redundantly encoded by two paralogous genes: H3.3A and H3.3B ([Fig. 5](#fig5){ref-type="fig"}). These are conserved in many organisms and, despite producing the same protein, they show different coding sequences, cis-regulatory targets, and intron-exon organization ([@bib17]; [@bib188]; [@bib23]; [@bib3]; [@bib5]; [@bib16]). Similar to CenH3^CENP-A^, H3.3A and H3.3B are solitary genes lacking 3′ stem-loop structure. Both give rise to polyadenylated transcripts, and H3.3B can generate up to three isoforms from alternative polyadenylation sites ([@bib5]; [@bib16]; [@bib49]). Although both H3.3A and H3.3B can contribute to new H3.3 synthesis, the two genes show distinct expression profiles in the male and female germline, among different tissues, and during development ([@bib89]; [@bib3]; [@bib16]; [@bib33]; [@bib81]; [@bib107]).

![**Cell cycle timing and regulation of the replacement variant H3.3.** The non-replicative variant H3.3 is deposited throughout the cell cycle by HIRA at regions of high turnover, such as regulatory sites and transcribed regions. H3.3 is expressed constitutively and redundantly encoded by two conserved paralogs: H3.3A and H3.3B. Both genes are located outside of histone clusters, contain introns, and give rise to polyadenylated mRNAs. H3.3A and H3.3B encode for the same protein, but their gene architecture is not conserved. They show distinct coding sequences, intron-exon organization, and cis-regulatory elements and are differentially expressed during development and among tissues. Putative binding sites have been identified in their respective promoter regions, and the CRE/TRE motif in H3.3B promoter was shown to mediate its activation via recruitment of AP-1 transcription factors. However, the basis of differences in expression is poorly understood. Similar to H3.1, the NASP histone chaperone can bind H3.3-H4 dimers and contributes to fine-tune protein levels via protection from chaperone-mediated autophagy.](JCB_201807179_Fig5){#fig5}

The cis-regulatory elements in the human H3.3B promoter include an octamer (Oct) motif and a combined cAMP- and TPA-responsive element (CRE/TRE) flanked by a TATA box and six CCAAT boxes ([@bib192]). Promoter deletion constructs show that the proximal promoter region, comprising Oct, CRE/TRE, and TATA elements, is sufficient to drive transcription in vitro ([@bib192]). The CRE/TRE sequence in H3.3B promoter can recruit TPA-inducible AP-1 factors ([@bib85]) and transcription factors of the CREB/ATF family that are typically activated via PKA-dependent phosphorylation in response to cAMP ([@bib114]). However, cAMP treatment does not significantly affect H3.3B levels in vitro, whereas TPA induces a strong transcriptional response that is dependent on the presence of an intact CRE/TRE motif ([@bib193]). This indicates a possible role for the recruitment of AP-1 factors through the TPA-inducible PKC pathway to induce H3.3B in vivo. However, additional players are likely involved in specific tissues or developmental stages and have not yet been characterized. Concerning H3.3A, it has a GC-rich promoter devoid of TATA and CCAAT boxes and instead harbors an ATA motif along with four SP1 binding sites. Stepwise deletion of the proximal promoter region, containing three SP1 motifs, reduces transcriptional activity in vitro in an additive manner ([@bib55]); however, the binding partners and mechanistic basis are largely unexplored. Hence, factors promoting H3.3A induction or differential expression in various tissues remain largely unknown.

Consequences of H3 variant alterations and imbalances {#s07}
=====================================================

As discussed, an incredible orchestration works to control the provision of histone proteins by multitasking at each possible level of regulation. Histones are always accompanied by chaperones, their guardians, throughout their cellular life ([@bib71]). The proper dosage of histone variants and chaperones plays an important role in defining the chromatin landscape during embryonic development, lineage commitment, and cell fate decisions ([@bib51]). *Xenopus* oocytes are protected from the surplus of histones by nucleoplasmin, sustaining chromatin assembly through the rapid cell divisions that occur during early development. In mammalian cells, replicative aging is associated with impaired histone synthesis ([@bib129]). This may be linked to chronic damage signals at telomeres that could affect histone levels ([@bib129]). Histone supply also affects the length of S phase and cell cycle progression ([@bib66], [@bib67]; [@bib69]). Interfering with SLBP, which reduces histone expression in human cells, also results in reduced cell growth and impaired S phase progression ([@bib207]). Intriguingly, the excess H3 during mitosis localizes to the centrosomes for proteasome-mediated degradation in worms, flies, and human cells ([@bib191]). The cross-talk with the centrosome could hence play a role in preserving chromosome integrity by coordinating different signaling events. Genes in the HIST1 cluster are significantly up-regulated across different breast cancer cell lines and breast tumor specimens ([@bib57]). The chromatin organizer CTCF, mutated in several cancers, is found at the boundaries between TADs associated with distinct gene subclusters. Considering that the nuclear organization of the HLB is compromised in cancer cells ([@bib61]), this could contribute to the misregulation of histone genes in tumors.

CenH3^CENP-A^ overexpression is common in many aggressive tumors ([@bib180]; [@bib8]; [@bib76]; [@bib101]; [@bib197]; [@bib139]; [@bib52]). These CenH3^CENP-A^ imbalances correlate with genomic instability and malignant progression as well as poor prognosis and response to treatment ([@bib173]; [@bib205]). CenH3 overexpression also leads to ectopic recruitment of kinetochore components and mitotic defects in both *Drosophila* ([@bib73]) and fission yeast ([@bib26]; [@bib64]). In human cells, overexpression of CenH3^CENP-A^ results in misassembly at chromosome arms ([@bib94]) in a cell cycle--independent manner ([@bib126]). Ectopic deposition is mediated by ATRX/DAXX and confers higher tolerance to DNA damage, a potential mechanism for resistance. Excess CenH3^CENP-A^ localizes at CTCF binding sites ([@bib94]), DNase I hypersensitive sites, and transcription factor binding sites across the genome ([@bib9]). Subtelomeric regions prone to instability are also hotspots for CenH3^CENP-A^ accumulation in overexpressing conditions ([@bib9]). Understanding how higher doses of CenH3^CENP-A^ can confer a selective advantage in genomically unstable cells will be important. Overexpression is associated with better tolerance to damage, but higher CenH3^CENP-A^ levels are also linked to chromosome instability and micronuclei formation in both cancer and stable diploid cells ([@bib160]). Future studies will certainly be critical to understand how histone imbalances and chromatin misassembly may lead to severe pathological implications.

Concerning H3.3, clear differences in expression between the two paralogs were observed in the fly and mouse male germlines ([@bib3]; [@bib16]; [@bib49]) and throughout preimplantation development in mammals ([@bib33]; [@bib83]; [@bib200]). In flies, H3.3A and H3.3B single knockouts are viable and fertile, whereas double-null mutants have low viability and are sterile ([@bib74]; [@bib152]). Hypomorphic H3.3B-null mice die postnatally, but single H3.3A knockouts are viable, with reduced male fertility ([@bib33]; [@bib177]). However, the effect of hypomorphic mutations depends on the genetic background ([@bib81]), and it is unclear what drives this variability among the paralogs. Notably, differences in expression could have important implications in tumorigenesis, because mutations in H3.3A and H3.3B are linked to distinct types of cancers ([@bib187]). Indeed, the impact and occurrence of somatic mutations differs between H3.3A and H3.3B ([@bib14]). K36 mutations, found in 95% of chondroblastomas and 7% of clear-cell chondrosarcomas, occur predominantly in the H3.3B gene. G34 and K27 mutations are instead nearly exclusive to H3.3A and linked to other types of tumors such as high-grade astrocytomas ([@bib157]; [@bib169]; [@bib196]; [@bib2]) and giant cell tumors of bone ([@bib14]; [@bib156]). The lysine 27 is encoded by an AAG codon in H3.3A and AAA in H3.3B; hence the chance of a specific substitution occurring in a given paralog can be explained in part by codon differences between H3.3A and H3.3B. K27 mutations are indeed also found in H3.1-coding genes, where, similar to H3.3A, the lysine is often encoded by a AAG codon ([@bib84]). However, differences in expression may affect the tissue specificity and outcome of specific amino acid substitutions, a possibility that has not been fully explored. Interestingly, duplication rates also vary between the two paralogs. Numerous H3.3 pseudogenes exist in both the human and mouse genome, and the majority are more closely related to H3.3A ([@bib189]; [@bib47]; [@bib107]). It is currently unknown whether genomic context or differential transcription has any impact on the outcome or propensity to genetic variation. Recent findings have provided insights into how alterations in multiple histone variants beyond H3 can cause changes in epigenome plasticity and genome stability, thereby driving cancer initiation and/or progression ([@bib183]; [@bib133]; [@bib19]). Understanding the regulation of distinct histone variants in normal conditions will be critical to gain insights into their role in cancer progression and open concrete avenues for future therapeutic strategies.

Concluding remarks {#s08}
==================

We have summarized the current knowledge concerning the transcriptional regulation of replicative and non-replicative histone variants. Their genomic organization and distinct features are a unique example of how an exquisite orchestration of events can contribute to handle the demands for histone variants under distinct physiological conditions. The coregulation of replicative variants, and the evolution of independent mechanisms that coordinate the production of non-replicative forms, may represent an interesting paradigm that could apply to other gene families. We have also learned a lot about the interplay among histone variants and their chaperones and how they shape the epigenome and sustain chromatin plasticity. In the future, it will be crucial to further investigate histone cross-talk in the variety of cell types that constitute an organism, under normal or pathological conditions. Multidisciplinary approaches and single-cell technologies will certainly play a pivotal role in the future to resolve the dynamics of chromatin architecture across different cells and over the lifetime of an individual.
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